Apple defeats Khosla-backed AliveCor lawsuit over its smartwatch tech

Apple has said the meeting was like hundreds of others it has hosted with developers over the years, with no pretense of a partnership

Apple watch, smartwatch
Photo: Bloomberg
Bloomberg
2 min read Last Updated : Feb 07 2024 | 7:26 AM IST
By Rachel Graf

Apple Inc. won’t have to face a lawsuit alleging its smartwatch copied heart-monitoring technology from a Khosla Ventures LLC-backed startup, AliveCor, a federal judge ruled. 
 
US District Judge Jeffrey White in Oakland, California, entered a judgment Tuesday in favor of Apple. Details of decision were filed under seal, due to confidentiality concerns by the companies. A redacted version will be made public in coming weeks. 

“AliveCor’s lawsuit challenged Apple’s ability to improve important capabilities of the Apple Watch that consumers and developers rely on, and today’s outcome confirms that is not anticompetitive,” Apple said in a statement.

AliveCor said it was “deeply disappointed” in the decision and plans to appeal. “We will continue to vigorously protect our intellectual property to benefit our consumers and promote innovation,” the company said in a statement. 

The dispute was based on a meeting in 2015, when AliveCor co-founder David Albert was invited by Apple executives to show off his heart-monitoring device, dubbed the KardiaBand. AliveCor claims Albert was told the iPhone maker intended to collaborate on the technology. 

Apple has said the meeting was like hundreds of others it has hosted with developers over the years, with no pretense of a partnership.

After 18 months of discussions between the companies, in “a clear attempt to steal AliveCor’s thunder,” Apple announced its own heart health initiative for the Apple Watch, a few hours after AliveCor informed Apple of the official launch date for the KardiaBand, according to the complaint. 

Over the next few years, as Apple updated the Watch operating system, no other service was allowed to offer heart-rate monitoring on the device because of the company’s “concentrated campaign to corner the market,” AliveCor claimed in its antitrust complaint. Apple denied that allegation and said it has allowed third-party apps to use its heart-rate sensor technology since 2015.

AliveCor said separate patent claims against Apple are still being litigated.
The case is AliveCor v. Apple, 21-cv-03958, US District Court, Northern District of California (Oakland).

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Apple IncsmartwatchApple Watch

First Published: Feb 07 2024 | 7:26 AM IST

Next Story